|
?:authorAffiliation
|
-
[\'Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Laboratory of Clinical and Evolutionary Virology, Leuven, Belgium. philippe.lemey@kuleuven.be.\', \'Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Laboratory of Clinical and Evolutionary Virology, Leuven, Belgium.\', \'Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, EH9 3FL, UK.\', \'INSERM, Sorbonne Université, Institut Pierre Louis d\'Epidémiologie et de Santé Publique IPLESP, F75012, Paris, France.\', \'Department of Immunology and Microbiology, Scripps Research, La Jolla, CA, 92037, USA.\', \'Department of Ecology and Evolutionary Biology, University of Arizona, Tucson, AZ, 85721, USA.\', \'Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, 20892, USA.\', \'Department of Biomathematics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA. msuchard@ucla.edu.\', \'Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, 90095, USA. msuchard@ucla.edu.\', \'Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA. msuchard@ucla.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}